Hope for thousands of MS patients as 'life-changing' drug now on NHS in England
Fampridine boosts nerve signals to make it easier to walk, with up to 5,000 eligible.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"it would make a huge difference to my life if I were able to improve my walking."
— Aysen Slack , Activist
"Walking difficulties can have a huge impact on the freedom and independence of people with MS, so this signal-boosting pill could be life-changing for thousands of patients."
— Prof Frankie Swords , Executive
"we were delighted by the news as the drug could be life-changing for many, allowing people to live more independently or stay in employment."
— Ceri Smith , Executive
Key People
Locations
All Coverage
Fampridine boosts nerve signals to make it easier to walk, with up to 5,000 eligible.
Similar Stories
Related coverage based on topic and tags
Endometriosis trial gives hope to millions of women in pain like me
A £2.3m study will look at whether a personalised pain management plan can improve the quality of life of women who have the debilitating condition.
September 30, 2026 at 05:21 AMUS FDA approves AbbVie's drug for Parkinson's disease - reuters.com
US FDA approves AbbVie's drug for Parkinson's disease reuters.com
September 25, 2026 at 10:57 PMHow a rapid new test is helping brain tumour patients
A rapid new test for brain tumours that the NHS has started using can slash the time it takes for an accurate diagnosis from up to eight weeks to two hours.
September 25, 2026 at 06:50 AMFrom weeks to hours - the rapid new test transforming brain tumour diagnosis
The test means patients can start treatment sooner and are spared weeks of uncertainty.
September 24, 2026 at 11:44 PMLilly's experimental drug cuts weight by 21% in diabetes trial - reuters.com
Lilly's experimental drug cuts weight by 21% in diabetes trial reuters.com
September 29, 2026 at 10:15 PMRegeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial - reuters.com
Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial reuters.com
September 30, 2026 at 10:30 PM